IL-17 antagonistic antibodies

Details IL-17 antagonistic antibodies IL-17 antagonistic antibodies

2005-08-04

2010-10-05

Bunner, Bridget E (Department: 1647)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

C530S387900, C530S388230, C530S350000, C435S069500, C435S326000, C536S023500

Reexamination Certificate

active

07807155

ABSTRACT:
An IL-17 binding molecule, in particular an antibody to human IL-17, more preferably a human antibody to human IL-17 is provided, wherein the hypervariable regions of the heavy and light chains have amino acid sequences as defined, for use in the treatment of an IL-17 mediated disease or disorder, e.g. rheumatoid arthritis.

REFERENCES:
patent: 5869286 (1999-02-01), Yao et al.
patent: 6043344 (2000-03-01), Jacobs et al.
patent: 6072033 (2000-06-01), Yao et al.
patent: 6072037 (2000-06-01), Yao et al.
patent: 6074849 (2000-06-01), Jacobs et al.
patent: 6096305 (2000-08-01), Yao et al.
patent: 6100235 (2000-08-01), Yao et al.
patent: 6274711 (2001-08-01), Golstein et al.
patent: 6562578 (2003-05-01), Gorman
patent: 7193064 (2007-03-01), Mikayama et al.
patent: 7456264 (2008-11-01), Keler et al.
patent: 2003/0223996 (2003-12-01), Ruben et al.
patent: 29820466 (1999-05-01), None
patent: 1053751 (2000-11-01), None
patent: 1933869 (2009-10-01), None
patent: 2000186046 (2000-07-01), None
patent: 95/18826 (1995-07-01), None
patent: 96/29408 (1996-09-01), None
patent: 97/04097 (1997-02-01), None
patent: 97/15320 (1997-05-01), None
patent: 98/23284 (1998-06-01), None
patent: 99/14240 (1999-03-01), None
patent: 99/24077 (1999-05-01), None
patent: 99/32632 (1999-07-01), None
patent: 99/35263 (1999-07-01), None
patent: 99/35267 (1999-07-01), None
patent: 99/41368 (1999-08-01), None
patent: 99/41369 (1999-08-01), None
patent: 99/41402 (1999-08-01), None
patent: 99/60127 (1999-11-01), None
patent: 00/15759 (2000-03-01), None
patent: 00/15798 (2000-03-01), None
patent: 00/20593 (2000-04-01), None
patent: 00/22909 (2000-04-01), None
patent: 00/29582 (2000-05-01), None
patent: 00/42187 (2000-07-01), None
patent: 00/42188 (2000-07-01), None
patent: 00/44349 (2000-08-01), None
patent: 00/47228 (2000-08-01), None
patent: 00/55204 (2000-09-01), None
patent: 00/69463 (2000-11-01), None
patent: 01/15728 (2001-03-01), None
patent: WO 02/02641 (2002-01-01), None
patent: 02/33083 (2002-04-01), None
patent: 02/058717 (2002-08-01), None
patent: 02/102411 (2002-12-01), None
patent: WO02/102411 (2002-12-01), None
patent: WO 03/055979 (2003-07-01), None
Hwang et al, Arthritis Research and Therapy, 2004, vol. 6, No. 2, pp. R120-R127.
R&D Systems: “Monoclonal Anti-human IL-17 Antibody”, R&D Systems Catalogue, ′Online, Jan. 11, 2004.
Chabaud M et al., “Contribution of Interleukin 17 to Synovium Matrix Destruction in Rheumatoid Arthritis”, Cytokine, Academic Press LTD, Philadelphia, PA, vol. 12, No. 7, pp. 1092-1090, (2000).
Database WPI, Section Ch, Week 200051, Derwent Publications Ltd., London, GB, AN 2000-551579, Jul. 4, 2000.
Lubberts Erik: “The role of IL-17 and family members in the pathogenesis of arthritis”, Current Opinionin in Investigational Drugs, vol. 4, No. 5, pp. 572-577, (2003).
Tak, P.P.; et al., 73rd Annu Sci Meet Am Coll Rheumatol , Abstract No. 1922 , (Oct. 20, 2009).
Stoll, D.: et al., 18th Congr Eur Acad Dermatol Venereol (EADV), Abstract No. P1138 (Oct. 7-11, Berlin) 2009.
Durez, P.; et al., Annu Eur Congr Rheumatol (EULAR), Abstract No. LB0002 (Jun. 10-13, Copenhagen 2009).
Egan, P.J.; et al., Arthritis Rheum, 58(12): 3720, 2008.
U.S. Appl. No. 11/502,622, filed Aug. 11, 2006.
Dumont F.J., “IL-17 Cytokind/Receptor Families: Emerging Targets for the Modulation of Inflammatory Responses”, Expert Opinion on Therapeutic Patents, vol. 13, No. 3, pp. 287-303, (2003).
Bhat, N. M. et al., Definition: Ig V kappa Ilb [human, mRNA Partial, 327 nt]., Database DDB/EMBL/GenBank [online], Accession No. S66 101, Nov. 29, 1993 uploaded, Apr. 8, 2010 http://www.ncbi.nlm.nih.govsviewer/viewer.fcgi ?430845:OLDID:553059.
The abstract Journal of the 45thJapan Digestive Disease Week, Sep. 20, 2003, p. A678.
The abstract Journal of the 45thJapan Digestive Week, Sep. 20, 2003, p. A675.
The abstract Journal of the 14thJapanese Society for Host Defense Research, Jul. 31, 2003, p. 33.
Kasai, N. et al., The Introductory immunology, Kodansha, 1989, the first edition, p. 41-42.
Japanese office action (translation) dated Apr. 20, 2010 (for corresponding JP Patent application No. 524286/2007).
Uk Search Report, dated Nov. 29, 2004, for corresponding case UK 0417487.6, filed Aug. 5, 2004.
Translation of The abstract Journal of the 45thJapan Digestive Week, Sep. 20, 2003, p. A678 (denoted “English Translation of Reference 6”).
Translation of The abstract Journal of the 45thJapan Digestive Week, Sep. 20 2003, p. A675 (denoted “English Translation of Reference 7”).
Translation of The abstract Journal of the 14thJapan Society for Host l efense Research, Jul. 31, 2003, p. 33 (denoted “English Translation of Reference 8”).
Translation of Kasai, N. et al., The Introductory immunology, Kodansha, 1989, the first edition, p. 41-42 (denoted “English Translation of Reference 9”).

Affiliated with

Also associated with

Rating

IL-17 antagonistic antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with IL-17 antagonistic antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IL-17 antagonistic antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4219748